1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: From randomized phase III S-TRAC study
    Journal Article

    George, D. J.; Martini, J. F.; Staehler, M.; Motzer, R. J.; Magheli, A.; Escudier, B.; Gerletti, P.; Li, S.; Casey, M.; Laguerre, B.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • The impact of patient education on consideration of enrollment in clinical trials
    Journal Article

    Mancini, J.; Briggs, A.; Elkin, E. B.; Regan, J.; Hickey, C.; Targett, C.; Ager, R.; Masuda, S.; Bach, P. B.; Sabbatini, P. J.
    Journal of Community and Supportive Oncology (2018)

    Fulltext@MSK | Save
  • Enhancing communication between oncology care providers and patient caregivers during hospice
    Journal Article

    Bauman, J. R.; Schleicher, S. M.; Nipp, R.; El-Jawahri, A.; Pirl, W. F.; Greer, J. A.; Temel, J. S.
    Journal of Community and Supportive Oncology (2018)

    Fulltext@MSK | Save
  • A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation
    Journal Article

    Ho, A. Y.; Olm-Shipman, M.; Zhang, Z.; Siu, C. T.; Wilgucki, M.; Phung, A.; Arnold, B. B.; Porinchak, M.; Lacouture, M.; McCormick, B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Tannir, N. M.; McDermott, D. F.; Arén Frontera, O.; Melichar, B.; Choueiri, T. K.; Plimack, E. R.; Barthélémy, P.; Porta, C.; George, S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia
    Journal Article

    Seymour, J. F.; Kipps, T. J.; Eichhorst, B.; Hillmen, P.; D'Rozario, J.; Assouline, S.; Owen, C.; Gerecitano, J.; Robak, T.; De La Serna, J.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): An international, randomised, phase 3, non-inferiority trial
    Journal Article

    Iveson, T. J.; Kerr, R. S.; Saunders, M. P.; Cassidy, J.; Hollander, N. H.; Tabernero, J.; Haydon, A.; Glimelius, B.; Harkin, A.; Allan, K.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): Two open-label, non-comparative, randomised, phase 2 trials
    Journal Article

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Atkins, J.; Milhem, M. M.; Jahagirdar, B. N.; Antonescu, C. R.; Horvath, E.; Tap, W. D.; Schwartz, G. K.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Early oral feeding following McKeown minimally invasive esophagectomy: An open-label, randomized, controlled, noninferiority trial
    Journal Article

    Sun, H. B.; Li, Y.; Liu, X. B.; Zhang, R. X.; Wang, Z. F.; Lerut, T.; Liu, C. C.; Fiorelli, A.; Chao, Y. K.; Molena, D.; more...
    Annals of Surgery (2018)

    Fulltext@MSK | Save
  • Exploring the cancer caregiver's journey through web-based Meaning-Centered Psychotherapy
    Journal Article

    Applebaum, A. J.; Buda, K. L.; Schofield, E.; Farberov, M.; Teitelbaum, N. D.; Evans, K.; Cowens-Alvarado, R.; Cannady, R. S.
    Psycho-Oncology (2018)

    Fulltext@MSK | Save